Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Deep Track Capital, LP reported a 7.00% stake in Aclaris Therapeutics, Inc. (Schedule 13G)
Event Mar 9, 2026 · Filed Mar 17, 2026
Deep Track Capital, LP reported a 7.00% stake in Aclaris Therapeutics, Inc., 9,345,000 shares, as a passive investor on Mar 9, 2026. Filed Mar 17, 2026 (Schedule 13G).
- Stake
- 7.00%
- Shares
- 9,345,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 7.00% | 9,345,000 |
| Deep Track Biotechnology Master Fund, Ltd. | 7.00% | 9,345,000 |
| David Kroin | 7.00% | 9,345,000 |
Source
Related
- Aclaris Therapeutics, Inc.
- Deep Track Capital, LP
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Schiff Andrew N · Jun 8, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026